Skip to content

Trial Summary

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.


ANZUP 1302

ACTRN/NCT /ethics:


Scientific title:

Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Sponsor / Cooperative group:

University of Sydney

Trial & Patient Characteristics

Cancer TypeOther
Trial TypeTreatment
PhasePhase III
Age Range11-45 years
Tumour Stream Germ cell
Cancer StageLocally Recurrent or Locally Advanced
Anticipated Start Date2014-02-01
Anticipated End Date2023-07-01

Participating Hospitals

HospitalIcon Cancer Centre Adelaide
Clinical Trial CoordinatorSue Yeend
Phone08 8292 2204
Principal InvestigatorProfessor Hsing Tan
Recruitment StatusRecruitment on Hold
HospitalRoyal Adelaide Hospital
Clinical Trial CoordinatorAnne Milton
Phone08 7074 2342
Principal InvestigatorDr Hsiang Tan
Recruitment StatusRecruiting